These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2772334)

  • 1. [Glipizide in the treatment of non-insulin-dependent diabetes mellitus].
    Luis Iriarte J
    Rev Clin Esp; 1989 Jun; 185(1):24-32. PubMed ID: 2772334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.
    Rosenstock J; Corrao PJ; Goldberg RB; Kilo C
    Clin Ther; 1993; 15(6):1031-40. PubMed ID: 8111800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects.
    Liu GC; Coulston AM; Lardinois CK; Hollenbeck CB; Moore JG; Reaven GM
    Arch Intern Med; 1985 Apr; 145(4):665-9. PubMed ID: 3885889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
    Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats.
    Nelson RW; Feldman EC; Ford SL; Roemer OP
    J Am Vet Med Assoc; 1993 Sep; 203(6):821-7. PubMed ID: 8226235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus.
    Aman M; Jawad F; Sultana S; Waiz-ul-Haq ; Nanji R
    J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of glipizide. Results of a multicentric study in Spain].
    Cerdeño VM; Passigli AG; Calvet J; Soler J
    Rev Iber Endocrinol; 1975; 22(127):43-60. PubMed ID: 1145006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
    Bandisode MS; Boshell BR
    Horm Metab Res; 1976 Mar; 8(2):89-91. PubMed ID: 770300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
    Saxena T; Maheshwari S; Goyal RK
    J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
    Borisova AM; Taneva T; Koev D; Georgieva R
    Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic clearance rate of insulin in type 2 diabetic patients treated with combined insulin and sulfonylurea therapy.
    Castillo MJ; Scheen AJ; Lefebvre PJ
    Rev Esp Fisiol; 1994 Mar; 50(1):27-34. PubMed ID: 7991936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Glipizide on the blood glucose and insulin in non-ketotic diabetes mellitus (author's transl)].
    Patsch W; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1976 Jan; 88(2):57-9. PubMed ID: 1258487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL; Fischer JS; Kipnes MS; Boyle M
    Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of first-generation sulfonylureas and glipizide in non-insulin-dependent diabetes mellitus.
    Beisswenger PJ; Dias N; Beckman F
    Am J Med; 1987 Sep; 83(3A):16-21. PubMed ID: 3631118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.